NPPA Fixes Retail Price Of 25 Formulations, Details Susmita Roy28 March 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of...
Revise CT protocol: CDSCO Panel tells Intas on antipsychotic Drug Endoxifen Dr. Divya Colin27 March 2023 6:00 PM ISTNew Delhi: Noting that the study drug Endoxifen is already approved in India since 10-12-2019 for proposed indication, the Subject Expert Committtee...
Emcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug Doravirine Dr. Divya Colin26 March 2023 6:00 PM ISTNew Delhi: Citing the unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has...
All SAEs including death should be reported: CDSCO Panel tells AstraZeneca about Durvalumab Dr. Divya Colin25 March 2023 6:00 PM ISTNew Delhi: Granting the protocol amendment proposal presented by drug major AstraZeneca for anticancer drug Durvalumab, the Subject Expert Committee...
Big Blow: JnJ loses patent battle of key tuberculosis drug Bedaquiline in India Farhat Nasim24 March 2023 2:50 PM ISTNew Delhi: As the world observes TB day, leading pharma giant Johnson and Johnson (JnJ) has faced a major blow as the Indian Patent Office on Thursday...
Novartis gets CDSCO panel nod for Phase III CT of anticancer drug Ianalumab Dr. Divya Colin23 March 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major Novartis has got the go-ahead from the Subject Expert Committee (SEC) functional under...
CDSCO panel grants GSK's proposal for Updation of Package Insert of Infanrix Hexa Vaccine Dr. Divya Colin22 March 2023 6:00 PM ISTNew Delhi: Pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche gets CDSCO panel nod to import, market anticancer Drug Polatuzumab vedotin Dr. Divya Colin21 March 2023 6:00 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO)...
CDSCO issued show cause notice to 31 firms following concerns over e-pharmacies: MoS Health Bharati Pravin Pawar Farhat Nasim20 March 2023 5:33 PM ISTCases concerning the quality of drugs, when reported, was taken up with the State Licensing Authority (SLA) concerned for necessary action under the...
FICCI jumps in support of e-pharmacies, writes to Health Ministry of show-cause notice Ruchika Sharma19 March 2023 12:30 PM ISTThe letter written by FICCI has also mentioned that there are no valid reasons that E-Pharmacies shouldn't operate in the India market place.
Presence of pharmacist mandatory in retail medical stores: DCGI to states, UTs drug controllers, PCI Ruchika Sharma18 March 2023 1:30 PM ISTNew Delhi: India's drug regulator DCGI has written to drug controllers of all states and Union territories and the Pharmacy Council of India asking...
Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
